Exploring the interface between metallo-proteinase activity and growth factor and cytokine bioavailability.
about
Soluble hemojuvelin is released by proprotein convertase-mediated cleavage at a conserved polybasic RNRR siteIL-13-induced proliferation of airway epithelial cells: mediation by intracellular growth factor mobilization and ADAM17Protein region important for regulation of lipid metabolism in angiopoietin-like 3 (ANGPTL3): ANGPTL3 is cleaved and activated in vivo.Xenobiotic exposure and autoimmune hepatitisChanges in the myocardial interstitium and contribution to the progression of heart failure.Plasminogen activator inhibitor-1 in the pathogenesis of asthma.Plasminogen is an important regulator in the pathogenesis of a murine model of asthmaMatrix metalloproteinase (MMP)-2 and MMP-9 in seminal plasmaCell adhesion-mediated radioresistance revisited.The role of inflammation in the pathogenesis of idiopathic pulmonary fibrosis.Drug releasing systems in cardiovascular tissue engineering.Matrix Metalloproteinases During Axonal Regeneration, a Multifactorial Role from Start to Finish.Tissue inhibitor of metalloproteinase-1 stimulates proliferation of human cancer cells by inhibiting a metalloproteinaseFGF-2 release from the lens capsule by MMP-2 maintains lens epithelial cell viability.Cigarette smoke exposure inhibits extracellular MMP-2 (gelatinase A) activity in human lung fibroblasts.Gastric gelatinase B/matrix metalloproteinase-9 is rapidly increased in Helicobacter felis-induced gastritis.Molecular profiling of ADAM12 and ADAM17 genes in human malignant melanoma.Adsorption of matrix metalloproteinases onto biomedical polymers: a new aspect in biological acceptance.Detection of the matrix metalloproteinases MMP-2 and MMP-9 and tissue inhibitors of metalloproteinases TIMP-1 and TIMP-2 in llama (Lama glama) oviduct.Influence of therapeutic hypothermia on matrix metalloproteinase activity after traumatic brain injury in rats.Implications for matrix metalloproteinases as modulators of pediatric lung disease.Morphological and molecular markers in idiopathic pulmonary fibrosis
P2860
Q24648048-14E0A44C-DB54-40A2-8D23-5968DB59F4A8Q30480054-4E4E2B36-E19F-40F4-92AD-712E6B8442CCQ34221134-B5D45A82-6CF5-426A-BFF6-9F69922D3579Q34495354-E02378D4-70AB-42E2-990D-7E47241A0F76Q35582221-4601EDCE-2262-4572-ABF2-4D6C29FD16F0Q35634264-6B1861BD-84EE-43F4-9928-48E54E8610E4Q36013653-EBED4C54-5E53-4758-81EE-20F2BA95D886Q36268675-78BED002-E099-42FF-9F32-4DFBD69BE4A8Q36977842-F758C2B2-1537-4BF2-B447-440A321F4C57Q36981609-ADA6F83C-4F39-49F2-AFE6-663D0B409569Q37451635-BC99FCF0-599A-4B10-9082-F7278F048BD0Q38754077-E825B061-FDD6-44DA-8BAD-3486E649E3C0Q38796484-34AF6037-AFD3-4B82-89A6-04C660E85ECAQ40093971-6249C35D-2F45-4E62-A2BB-0199C4EF47CDQ40160262-8F2E6BB0-CDDD-4061-B219-26F13065D683Q42521347-CE8061E7-E88C-4F5E-A8BB-C16812E7C981Q43650121-D25DB13B-E9FB-4339-866A-34CB289730FFQ46821482-24878CF5-A8F6-4241-9ACD-FDA92AD2D1ACQ48603811-2AEC1725-F69E-4DFB-A71B-6100C0DF8645Q48852577-0B711418-0E56-4F1F-AA88-7098083C17F3Q51696061-EDD22258-6A96-4F29-A6A1-15E9E1B449D5Q58004304-DF9FCF51-0C1C-4D44-A8A3-D3B18F97F130
P2860
Exploring the interface between metallo-proteinase activity and growth factor and cytokine bioavailability.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Exploring the interface betwee ...... and cytokine bioavailability.
@ast
Exploring the interface betwee ...... and cytokine bioavailability.
@en
type
label
Exploring the interface betwee ...... and cytokine bioavailability.
@ast
Exploring the interface betwee ...... and cytokine bioavailability.
@en
prefLabel
Exploring the interface betwee ...... and cytokine bioavailability.
@ast
Exploring the interface betwee ...... and cytokine bioavailability.
@en
P1476
Exploring the interface betwee ...... and cytokine bioavailability.
@en
P2093
John L Fowlkes
Margaret K Winkler
P304
P356
10.1016/S1359-6101(02)00005-9
P577
2002-06-01T00:00:00Z